Pages tagged with: antibiotic
-
World Antimicrobial Awareness Week (WAAW)
What's on at the University of Plymouth: World Antimicrobial Awareness Week (WAAW). Increasing awareness of global antimicrobial resistance (AMR). 18-24 November 2020.
-
PLymouth ANtimicrobial EngagemenT (PLANET) Initiative
University of Plymouth research: PLymouth ANtimicrobial EngagemenT (PLANET) Initiative. Highlighting the issue of antimicrobial resistance.
-
Amprologix: developing the next generation of antibiotics
Amprologix is a University of Plymouth spinout company working with Ingenza Ltd to develop new antibiotics that will aid with battling antimicrobial resistance.
-
Antibiotic resistant pathogens research group
Antibiotic resistant at Faculty of Medicine and Dentistry. Internationally recognised for development of novel antibiotics and investigation of uropathogenic E coli
-
Antibiotic resistant pathogens research group projects
Antibiotic resistant pathogens research group projects at the University of Plymouth.
-
Antibiotic resistant pathogens research group publications
University of Plymouth: The research publications of the Antibiotic resistant pathogens research group, led by Professor Mat Upton.
-
Antibiotic resistance and the quest for discovery – Professor Mathew Upton (POSTPONED)
What's on at the University of Plymouth: The Inaugural Professorial Lecture of Professor Mathew Upton, medical microbiologist investigating antibiotic resistance. Thursday 26 March 2020.
-
Academic named ‘Jewel of India’ in recognition of international impact
Dr Tina Joshi, a Lecturer in Molecular Microbiology at the University of Plymouth, has received an award from the Indian Government in recognition of her international impact in her field.
-
Antibiotic resistant pathogens research group team
Plymouth University research: Antibiotic Resistant Pathogens Research Group team. Meet our team and collaborators
-
Partnership to develop production system for exciting new antibiotic
Plymouth University news: A collaboration between Plymouth University and Ingenza will develop an efficient, scalable production system for a new antibiotic, the first in 30 years, and designed to fight antibiotic-resistant bacteria.